AC-HPAT Biology Practice Exam 2026 - Free Biology Practice Questions and Study Guide

Stem cell transplants for leukemia are designed to replace the abnormal leukemia cells with healthy blood-making stem cells. This is achieved through a process where either the patient's own stem cells (autologous transplant) or donor stem cells (allogeneic transplant) are used to reestablish healthy blood production. The primary goal is to generate a new population of healthy blood cells that can replace the defective ones causing leukemia.

Successful stem cell transplants can provide a new supply of healthy hematopoietic stem cells, which are responsible for producing all types of blood cells, including red blood cells, white blood cells, and platelets. This can help to restore normal blood function and improve the overall health of individuals suffering from leukemia.

Other options may contain misconceptions; for example, transplants do not strictly use only the patient’s own stem cells, and they can be effective therapies even in the context of bone marrow cancers, but they do not always guarantee complete recovery and can come with various risks and complications.